Hopital Huriez
- Address
- lock Available on a paid plan
Digestive System Diseases
The department is investigating new therapies for primary biliary cholangitis‑related itching and assessing peri‑operative treatment options for colon cancer with mismatch repair deficiency.
- Primary biliary cholangitis – cholestatic pruritus
- Resectable colon cancer – dMMR/MSI‑H
Hopital Huriez conducts eight trials with a team of 25 investigators, emphasizing patient‑focused outcomes in digestive health.
Hemic and Lymphatic Diseases
Studies target advanced blood‑cell malignancies, evaluating novel conditioning regimens for transplant and a bispecific antibody in Mantle Cell Lymphoma.
- Mantle Cell Lymphoma
- Acute myeloid leukemia
The research aims to improve survival and reduce treatment‑related toxicity for patients with hematologic cancers.
Immune System Diseases
Clinical work focuses on autoimmune conditions, testing long‑term safety of a novel agent in Sjögren’s syndrome and measuring disease activity reduction in systemic lupus erythematosus.
- Sjögren’s syndrome
- Systemic lupus erythematosus
These trials seek to provide better symptom control and disease‑modifying options for patients with immune‑mediated disorders.
Neoplasms
The site evaluates innovative cancer therapies, including a single‑agent bispecific antibody for relapsed Mantle Cell Lymphoma and a checkpoint inhibitor used before surgery in colon cancer.
- Mantle Cell Lymphoma
- Colon cancer – resectable disease
By comparing progression‑free survival and overall outcomes, the research supports advances in solid‑tumor and hematologic oncology.
Virus Diseases
A trial investigates the efficacy of an AXL‑inhibitor in hospitalised patients with moderate SARS‑CoV‑2 infection, aiming to reduce disease severity.
- COVID‑19
The study contributes to the development of targeted treatments for emerging viral threats.
Environment and Public Health
Through its infectious‑disease program, the centre supports broader public health goals by generating evidence on safe, effective therapies that can be deployed in community settings.
- Infectious disease clinical research
- Trial infrastructure for population health
The work at Hopital Huriez helps inform health policies and preparedness strategies across the region.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 11 therapeutic areas and 15 of 76 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 73 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 11 by active trials.
lock +10 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novartis Pharma AG4trials
lock +3 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hopital Huriez
lock Showing 1 of 30 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized Controlled Trial on Fecal Microbiota Transplantation Versus Sodium Chloride for Recurrent Pouchitis in Ulcerative Colitis with IPAA | Centre Hospitalier Universitaire De Nantes | Phase III | Not Recruiting | Jan 2026 | — |
IMP list
lock Showing 1 of 76 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Fluorouracil | 4 | Unknown | 2023-05-22 | 2026-06-09 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.